Autonomix Medical Inc.

AMIX | undefined

Price Alert Chart Builder DCF Calculator

At close: undefined

After-hours:

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

undefined%

(1Y)

Rating

Updated: Aug 17, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $-

1D Range

52W Range

Valuation (TTM)

PE -0.09

PB 0.70

EV/EBITDA 0.08

Valuation (NTM)

Forward PE N/A

Forward PEG 0.01

Price Target $2

Cash Flow

FCF Yield -549.4%

SBC Adj. FCF Yield -549.7%

SBC Impact 0.0%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 40.2% | N/A

FCF 3Y | 5Y -20.2% | N/A

Returns

ROA -404.7%

ROE -267.7%

ROIC -518.1%

Financial Health

Net Cash

$3.46M

Current Ratio 4.85

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s techn...

Sector Healthcare

Industry Medical - Devices

Employees 10

IPO Date Jan 28, 2024

Website autonomix.com

Fiscal Year April - March

Full Company Profile

Latest News

No news articles available yet.